<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02352480</url>
  </required_header>
  <id_info>
    <org_study_id>CM002 Gold</org_study_id>
    <nct_id>NCT02352480</nct_id>
  </id_info>
  <brief_title>Effectiveness of Aurix Therapy in Diabetic Foot Ulcers</brief_title>
  <official_title>A Multi-Center, Prospective, Randomized Trial Comparing the Effectiveness of Aurix Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nuo Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nuo Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to demonstrate the effectiveness of complete wound healing in a
      prospective, open-label, randomized trial in which diabetic food ulcers (DFU) will be treated
      using Aurix plus Usual and Customary Care (UCC) and compared to a group receiving just UCC as
      provided in up to 100 U.S. wound centers
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aurix is a platelet-rich plasma gel used in the treatment of non-healing chronic wounds.
      Prospective observational studies of the effectiveness of Aurix have demonstrated promising
      results in regard to the healing of DFUs, including severe Wagner grade 3 and 4 ulcers. The
      aim of this trial is to demonstrate the of complete wound healing in a prospective,
      open-label, randomized trial in which diabetic foot ulcers will be treated using Aurix to
      determine the time to heal at 12 weeks. Comparison will be made on a 1:1 basis of Aurix + UCC
      versus control subjects receiving undefined UCC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to heal</measure>
    <time_frame>12 weeks</time_frame>
    <description>The primary endpoint of the trial is determine the time to heal diabetic foot ulcers treated with Aurix and Standard of Care at 12 weeks. Comparison will be made with the control arm of subjects treated only with Standard of Care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of amputations</measure>
    <time_frame>12 weeks</time_frame>
    <description>Frequency of lower extremity amputations; major/minor amputations will be tabulated but not tested.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of completely healed ulcers</measure>
    <time_frame>12 weeks</time_frame>
    <description>Proportion of patients with completely healed diabetic foot ulcers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>W-QOL (Quality of life with chronic wounds) score</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in mean W-QOL (Quality of life with Chronic Wounds) score between baseline and 12 weeks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">760</enrollment>
  <condition>Diabetic Foot Ulcers</condition>
  <arm_group>
    <arm_group_label>Aurix + UCC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be treated on average twice a week for the first 2 weeks, and then, once a week thereafter while under active treatment, but actual frequency of treatment will be determined by the treating physician. All subjects will receive Aurix treatment plus usual and customary care, which can include any advanced therapeutics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual and Customary Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will be treated on average twice a week for the first 2 weeks, and then, once a week there after while receiving usual and customary care, but actual frequency of visits will be determined by the treating physician. Usual and customary care, which can include any advanced therapeutics.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aurix</intervention_name>
    <description>Aurix is a platelet-rich plasma (PRP) gel used in the treatment of non-healing chronic wounds. It will be administered twice weekly for 2 weeks then weekly.</description>
    <arm_group_label>Aurix + UCC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Medicare eligible

          2. ≥18 years of age

          3. Type I or II diabetes requiring medical treatment as determined by the physician

          4. The largest non-healing wound, if multiple wounds are present, or the single wound to
             be treated (Index Ulcer) is a Wagner 1-5 DFU (see Appendix 9 for Wagner
             Classification) that is located on the dorsal, plantar, medial, or lateral aspect of
             the foot or heel (including all toe surfaces)

          5. For subjects with potentially multiple eligible DFUs, the largest ulcer will be
             selected as the Index Ulcer for study. There must be at least 4 cm between the Index
             Ulcer and other ulcers; if all ulcers are closer than 4 cm, the subject should not be
             enrolled (screen failure)

          6. Debrided ulcer size between 0.5 cm2 and 50 cm2

          7. Subject has received UCC care for ≥ 2 weeks at treating wound clinic

          8. Demonstrated adequate offloading regimen

          9. Duration ≥ 1 month at first visit

         10. Subject must be willing to comply with the Protocol, which will be assessed by
             enrolling clinician.

        Exclusion Criteria:

          1. Subjects known to be sensitive to Aurix components (calcium chloride, thrombin,
             ascorbic acid) and/or materials of bovine origin

          2. Presence of another wound that is concurrently treated and might interfere with
             treatment of the index wound by Aurix

          3. Ulcer not of DFU pathophysiology (e.g., venous, vasculitic, radiation, rheumatoid,
             collagen vascular disease, pressure, or arterial etiology)

          4. Patients on chemotherapeutic agents or any malignancy in the wound area

          5. Subjects who are cognitively impaired

          6. Serum albumin of less than 2.5 g/dL

          7. Plasma Platelet count of less than 100 x 109/L

          8. Hemoglobin of less than 10.5 g/dL

          9. Subject has inadequate venous access for repeated blood draw required for Aurix
             administration.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Clausen, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Nuo Therapeutics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stacy Gardner</last_name>
    <phone>240-406-1816</phone>
    <email>sgardner@nuot.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Methodist Hospital Wound Care Center</name>
      <address>
        <city>Arcadia</city>
        <state>California</state>
        <zip>91007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Villarama</last_name>
      <phone>626-898-8927</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beverly Hospital Wound and Hyperbaric Center</name>
      <address>
        <city>Montebello</city>
        <state>California</state>
        <zip>90640</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar Sabha</last_name>
      <phone>323-726-1222</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaweah Delta Rehabiliation Hospital</name>
      <address>
        <city>Visalia</city>
        <state>California</state>
        <zip>93277</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klara Bergholdt</last_name>
      <phone>559-624-3944</phone>
      <email>kbergtho@kdhcd.org</email>
    </contact>
    <investigator>
      <last_name>Beth Hirsch, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bristol Hospital Wound Care Center</name>
      <address>
        <city>Bristol</city>
        <state>Connecticut</state>
        <zip>06410</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristopher Jones</last_name>
      <phone>860-585-3397</phone>
      <email>kristopher.jones@restorixhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Piedmont</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Devine, MD</last_name>
      <phone>404-351-8873</phone>
    </contact>
    <contact_backup>
      <last_name>Teri Biven</last_name>
      <phone>404-351-8873</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Luke's Wound and Hyperbaric Center</name>
      <address>
        <city>Meridian</city>
        <state>Idaho</state>
        <zip>86342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lydia Nixt</last_name>
      <phone>208-489-4326</phone>
      <email>nixtl@slhs.org</email>
    </contact>
    <investigator>
      <last_name>Warren Gude</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Wound Healing at FHN</name>
      <address>
        <city>Freeport</city>
        <state>Illinois</state>
        <zip>61032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Casey Euell, RN</last_name>
      <phone>815-599-7410</phone>
      <email>Ceuell1@fhn.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center - Center for Wound Healing</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryne Beasley</last_name>
      <phone>617-636-5287</phone>
      <email>kbeasley@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Geneve Allison, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Joseph Mercy Oakland Hospital Center for Wound Care and Hyperbaric Medicine</name>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <zip>48341</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Cardwell, RN</last_name>
      <phone>248-858-2606</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Catskill Regional Medical Center - Wound Healing Center</name>
      <address>
        <city>Harris</city>
        <state>New York</state>
        <zip>12742</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Johnston</last_name>
      <phone>845-794-4620</phone>
      <email>jennifer.johnston@restorixhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orange Regional</name>
      <address>
        <city>Middletown</city>
        <state>New York</state>
        <zip>10940</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Hinson</last_name>
      <phone>845-333-7706</phone>
      <email>jessica.hinson@restorix.health.com</email>
    </contact>
    <investigator>
      <last_name>Inocencia Carrano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Wound Center of Niagara</name>
      <address>
        <city>Niagara Falls</city>
        <state>New York</state>
        <zip>14301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cassandra Laflair, RN</last_name>
      <phone>716-278-4424</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onslow Memorial Hospital - Wound Care and Hyperbaric Center</name>
      <address>
        <city>Jacksonville</city>
        <state>North Carolina</state>
        <zip>28546</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandi Moore</last_name>
      <phone>910-577-4977</phone>
      <email>brandi.moore@restorixhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Center for Wound Healing Crozer Chester Medical Center</name>
      <address>
        <city>Chester</city>
        <state>Pennsylvania</state>
        <zip>19013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Barrett, DPM</last_name>
      <phone>610-619-8400</phone>
      <email>christopher.barrett@restorixhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Memorial City</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Shafer</last_name>
      <phone>713-242-4325</phone>
      <email>rachel.shafer@restorixhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann South West</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Stubbs</last_name>
      <phone>713-456-6100</phone>
      <email>katherine.stubbs@memorialhermann.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann South East</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77089</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eber Lopez</last_name>
      <phone>832-658-5100</phone>
      <email>eber.lopez@memorialhermann.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Katy Rehab</name>
      <address>
        <city>Katy</city>
        <state>Texas</state>
        <zip>77450</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamey Rush</last_name>
      <phone>281-579-5542</phone>
      <email>jamey.rush@memorialhermann.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mary's Wound and Hyperbaric Center</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabrina Briggs, RN</last_name>
      <phone>304-399-7450</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Center for Wound Healing Cabell Huntington Hospital</name>
      <address>
        <city>Huntington</city>
        <state>West Virginia</state>
        <zip>25703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandi Dillon, RN</last_name>
      <phone>304-399-3510</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2015</study_first_submitted>
  <study_first_submitted_qc>January 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2015</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non Healing Wound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

